Your browser doesn't support javascript.
loading
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Wirtz, Theresa H; Loosen, Sven H; Schulze-Hagen, Max; Gorgulho, Joao; Kandler, Jennis; Joerdens, Markus; Demir, Münevver; Mohr, Raphael; Bruners, Philipp; Kuhl, Christiane; Trautwein, Christian; Berres, Marie-Luise; Tacke, Frank; Luedde, Tom; Roderburg, Christoph.
Afiliação
  • Wirtz TH; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Loosen SH; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Schulze-Hagen M; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Gorgulho J; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Kandler J; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Joerdens M; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Demir M; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
  • Mohr R; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
  • Bruners P; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Kuhl C; Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Trautwein C; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Berres ML; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Tacke F; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany.
  • Luedde T; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Roderburg C; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Clin Transl Sci ; 14(5): 1853-1863, 2021 09.
Article em En | MEDLINE | ID: mdl-33787014
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Fatores Inibidores da Migração de Macrófagos / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Oxirredutases Intramoleculares / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Fatores Inibidores da Migração de Macrófagos / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Oxirredutases Intramoleculares / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article